By Mill Chart
Last update: May 15, 2025
HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) stands out as an affordable growth stock based on our screening criteria. The company combines strong growth prospects with reasonable valuation metrics, while maintaining solid financial health and profitability.
HRMY demonstrates impressive growth, scoring a 9 out of 10 in our growth rating. Key highlights include:
With a valuation rating of 9, HRMY appears reasonably priced:
The company maintains strong financials:
For a deeper look, review the full fundamental analysis of HRMY.
Our Affordable Growth screener lists more stocks with similar characteristics and is updated daily.
This is not investing advice! The article highlights observations at the time of writing, but you should conduct your own analysis before making investment decisions.
35.16
-0.15 (-0.42%)
Find more stocks in the Stock Screener
Harmony Biosciences (HRMY) shows strong growth, profitability, and a bullish technical pattern, making it a stock worth watching in the pharmaceuticals sector.
Harmony Biosciences (HRMY) shows strong growth, profitability, and financial health while trading at an attractive valuation, making it a potential pick for value investors.